CHRISTOPHER CHARLES: Open Payments
NPI 1114241965 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 27 payments from 6 companies in 2025. Trend: 2023 $190 · 2024 $445 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $172 |
| ABBVIE INC. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: FANAPT, VRAYLAR, SPRAVATO, COBENFY, HETLIOZ, TRINTELLIX, AUSTEDO XR.
Industry payments across NV — which companies pay providers there.
